Volume dodolan perusahaan agenusbio.com (AGEN)
Competition in immuno-oncology and financial difficulties are eroding the market advantages of Agenus (AGEN). Monitoring of the company's sales demonstrates volatility, with the value holding at 0.13. Unpredictable cash inflows and costly development create risks, however, the diversification of the antibody portfolio through collaboration with pharma behemoths minimizes potential losses from individual clinical trial failures.
Rincian metrik komprehensif lan analitis Agenus Inc. (AGEN)
- rega lan prakiraan konsensus rega:
- rincian kapitalisasi pasar:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Rasio Utang marang Modal Agenus|AGEN - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Agenus, Inc.|AGEN - Utang perusahaan|Rasio utang marang nilai buku Agenus Inc.|AGEN - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Agenus|Koefisien jangkoan perantara agenusbio.com
- data bathi bisnis lan rasio investasi:
AGEN - Bathi resik|Proyeksi bathi mangsa ngarep Agenus|AGEN - Pangali P/E|Pangali forward rega marang bathi agenusbio.com|AGEN - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Agenus Inc.|AGEN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone 12 wulan pungkasan Agenus|AGEN - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan agenusbio.com|AGEN - Wutah bathi ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Agenus
- statistik dodolan lan pendapatan perusahaan:
Analisis komprehensif perusahaan:Agenus, Inc AGEN
Agenus creates innovative antibodies to combat colorectal cancer, competing with global market leaders. Daily sales volume allows for a real-time assessment of actual revenue and the business's resilience to market shocks. For an investor, such granularity is critical when analyzing the recovery speed of operating cash flows. Revenue dynamics confirm the commercial value of patient survival data. Analyzing the sales levels of Agenus helps identify risks of capital drawdown.
Perusahaan pesaing
Pendapatan lan volume dodolan argenx BVBA|Pendapatan perusahaan BioNTech SE (BNTX)|Abivax SA - Volume dodolan perusahaan|Pendapatan lan volume dodolan ADMA (ADMA Biologics, Inc.)|Protagonist Therapeutics, Inc. (PTGX) - Total pendapatan perusahaan|Immunovant Corp - Pendapatan lan volume dodolan|KNSA - Pendapatan lan volume dodolan|GRFS: Pendapatan lan volume dodolan|Total volume dodolan perusahaan adaptivebiotech.com ADPT|CLDX (Celldex Therapeutics, Inc.) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Aurinia Pharmaceuticals Inc AUPH|Pendapatan perusahaan BioCryst Pharmaceuticals Inc (BCRX)|Vera Corp - Volume dodolan perusahaan|Dianthus Therapeutics - Dodolan perusahaan|Pendapatan lan volume dodolan pharvaris.com PHVS|ABCL - Pendapatan perusahaan|Pendapatan reged perusahaan Tourmaline Bio Inc TRML|PGEN: Pendapatan lan volume dodolan|Pharming Corp (PHAR) - Pendapatan lan volume dodolan|NKTR (Nektar Therapeutics) - Pendapatan lan volume dodolan|UPB - Total volume dodolan perusahaan|Pendapatan lan volume dodolan ZBIO|IMNM - Total pendapatan perusahaan|Pendapatan perusahaan Gossamer Corp GOSS|KALV: Volume dodolan perusahaan|SEPN - Pendapatan perusahaan|Pendapatan tahunan perusahaan PVLA|SVRA: Pendapatan lan volume dodolan|Rigel Pharma - Pendapatan dodolan perusahaan|ANAB (AnaptysBio Corp) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan Astria Corp|Pendapatan perusahaan enGene Holdings Inc. (ENGN)|RAPT (rapt.com) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Aerovate Therapeutics JBIO|ACRS - Dodolan perusahaan|Kyverna - Pendapatan lan volume dodolan|TLSA - Pendapatan lan volume dodolan|CABA (Cabaletta Bio, Inc.) - Dodolan perusahaan|ventyxbio.com - Pendapatan dodolan perusahaan|THTX (Theratechnologies) - Pendapatan lan volume dodolan|Avalo Therapeutics, Inc. (AVTX) - Pendapatan reged perusahaan|Pendapatan perusahaan Eledon (ELDN)|Dodolan perusahaan Climb Bio, Inc CLYM|Pendapatan perusahaan Zura Bio Limited ZURA|ATYR - Dodolan perusahaan|ADAG: Dodolan perusahaan|IMA - Pendapatan lan volume dodolan|shattucklabs.com (STTK) - Pendapatan perusahaan|Volume dodolan perusahaan EQ|CNTB (Connect Biopharma Holdings) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Immunic Inc IMUX|Pendapatan lan volume dodolan ATRA|Pendapatan lan volume dodolan inflarx.de (IFRX)|Pendapatan lan volume dodolan XFOR (X4 Pharma)|Total volume dodolan perusahaan Adicet Bio Inc.|Celularity Corp - Pendapatan lan volume dodolan|Total pendapatan perusahaan inmunebio.com|Barinthus Biotherapeutics plc (BRNS) - Pendapatan perusahaan|Volume dodolan perusahaan KZR|Dodolan perusahaan SABS|Pendapatan lan volume dodolan Akari Therapeutics, Plc|Pendapatan perusahaan Enlivex Therapeutics (ENLV)|Pendapatan reged perusahaan q32bio.com|Pendapatan lan volume dodolan GOVX (GeoVax)|Pendapatan lan volume dodolan Edesa Biotech Inc EDSA|iBio Corp - Pendapatan lan volume dodolan|Total volume dodolan perusahaan Carisma Therapeutics (CARM)|XTLB: Pendapatan lan volume dodolan|Total pendapatan perusahaan Bolt Biotherapeutics, Inc. (BOLT)|Pendapatan perusahaan HCW Biologics, Inc.|Volume dodolan perusahaan APVO (Aptevo)|Pendapatan perusahaan AIM ImmunoTech (AIM)|ADTX: Pendapatan tahunan perusahaan|Pendapatan lan volume dodolan GRI (GRI Bio, Inc.)|Pendapatan dodolan perusahaan XRTX|Vyome Holdings - Pendapatan lan volume dodolan|REVB - Pendapatan lan volume dodolan|Indaptus (INDP) - Pendapatan perusahaan|BiondVax Pharmaceuticals - Pendapatan dodolan perusahaan|Pendapatan perusahaan CalciMedica Inc|Dodolan perusahaan Affimed Therapeutics (AFMD)|Pendapatan lan volume dodolan ALLK|Pendapatan lan volume dodolan hookipapharma.com (HOOK)|IGM Biosciences - Dodolan perusahaan|Pendapatan dodolan perusahaan ITOS|Ocean Biomedical, Inc. - Pendapatan lan volume dodolan|Pendapatan reged perusahaan tcbiopharm.com TCBP|Third Harmonic Bio, Inc. (THRD) - Pendapatan perusahaan
